Skip to main content
SpringerLink
Log in
Book cover

31st Hemophilia Symposium Hamburg 2000 pp 257–261Cite as

Do Statins Increase the Homocysteine Level?

  • Conference paper

  • 109 Accesses

Abstract

Besides their cholesterol-lowering effect, statins are also useful for reducing C-reactive protein (CRP). Patients with higher CRP values have a double risk of apoplexy and a threefold infarct risk compared with patients with low values.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Dangas G, Smith D A, Unger A H, Shao J H et al: Pravastatin: an antithrombotic effect independent of the cholesterol-lowering effect. Thromb Haemost 2000; 83: 688–92

    PubMed  CAS  Google Scholar 

  2. deLorgeril M, Paillard F, Lacan P, Richard G: Lipidlowering drugs and homocysteine. Lancet 1999; 353: 209

    Article  CAS  Google Scholar 

  3. Dierkes J, Westphal S, Luley C: Serum homocysteine increases after therapy with fenofibrate or bezafibrate. Lancet 1999; 354: 219

    Article  PubMed  CAS  Google Scholar 

  4. Jonkers I J A M, de Man F H A F, Onkenhout W, van der Laarse A, Smelt A H M: Implication of fibrate for homocysteine. Lancet 1999; 354: 1208

    Article  PubMed  CAS  Google Scholar 

  5. LIPID Study Group: Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998; 339: 1349–57

    Article  Google Scholar 

  6. Ross SD, Allen IE, Connelly JE et al.: Clinical outcomes in statin treatment trials. Arch Intern Med 1999; 159: 1793–802

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. M. Von Lieven
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Rössig
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Vigh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Rabenstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. I. Scharrer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hemophilia Center, Dept. of Internal Medicine, University Hospital, Theodor-Stern-Kai 7, D-60590, Frankfurt am Main, Germany

    Inge Scharrer

  2. Dept. of Hemostasiology, University Hospital, Ziemssenstr. 1a, D-80336, München, Germany

    Wolfgang Schramm

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Von Lieven, M., Rössig, L., Vigh, T., Rabenstein, C., Scharrer, I. (2002). Do Statins Increase the Homocysteine Level?. In: Scharrer, I., Schramm, W. (eds) 31st Hemophilia Symposium Hamburg 2000. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59383-3_38

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59383-3_38

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-42131-3

  • Online ISBN: 978-3-642-59383-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation